Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 15, Pages 8199
Publisher
MDPI AG
Online
2021-07-31
DOI
10.3390/ijms22158199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma
- (2021) Flora Cimmino et al. Frontiers in Oncology
- Targeting RNF8 effectively reverses cisplatin and doxorubicin resistance in endometrial cancer
- (2021) Ben Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
- (2021) Scarlett Acklin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The use of genomic assays reduces rates of chemotherapy: a single-institution experience
- (2021) Jamie Vatish et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer
- (2021) Kaili Long et al. Cell Death & Disease
- FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers
- (2021) Katia A. Mesquita et al. Cancers
- Integrated Analysis of Whole Genome and Epigenome Data Using Machine Learning Technology: Toward the Establishment of Precision Oncology
- (2021) Ken Asada et al. Frontiers in Oncology
- Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer
- (2021) Cynthia Aristei et al. Frontiers in Oncology
- Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers
- (2021) Yuzuka Kanno et al. Frontiers in Oncology
- Discovery and validation of a genomic signature to identify women with early-stage invasive breast cancer who may safely omit adjuvant radiotherapy after breast-conserving surgery.
- (2021) Martin Sjöström et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data
- (2021) Myrto Moutafi et al. ORAL ONCOLOGY
- CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma
- (2020) Beatriz Salvador-Barbero et al. CANCER CELL
- EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition
- (2020) Sergey Karakashev et al. CANCER CELL
- Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment
- (2020) Yufeng Liu et al. CELL BIOCHEMISTRY AND FUNCTION
- CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms
- (2020) Margaretha A. Skowron et al. BRITISH JOURNAL OF CANCER
- Chloride – The Underrated Ion in Nociceptors
- (2020) Bettina U. Wilke et al. Frontiers in Neuroscience
- A randomized, double-blind, placebo-controlled study of B-cell lymphoma 2 homology 3 mimetic gossypol combined with docetaxel and cisplatin for advanced non-small cell lung cancer with high expression of apurinic/apyrimidinic endonuclease 1
- (2020) Yuxiao Wang et al. INVESTIGATIONAL NEW DRUGS
- RNF8 promotes epithelial-mesenchymal transition in lung cancer cells via stabilization of Slug
- (2020) Jingyu Kuang et al. MOLECULAR CANCER RESEARCH
- Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
- (2020) Jayakumar Nair et al. ONCOGENE
- Sclareol ameliorated ERCC1-mediated cisplatin resistance in A549 human lung adenocarcinoma cells and a murine xenograft tumor model by suppressing AKT-GSK3β-AP1/Snail and JNK-AP1 pathways
- (2020) Chun-Hsu Pan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Role of Nucleotide Excision Repair in Cisplatin Resistance
- (2020) Mingrui Duan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical Perspectives of ERCC1 in Bladder Cancer
- (2020) Konstantinos Koutsoukos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells
- (2019) Xue Teng et al. ONCOLOGY REPORTS
- Platinum Resistance in Ovarian Cancer: Role of DNA Repair
- (2019) Giovanna Damia et al. Cancers
- Spironolactone‐induced XPB degradation depends on CDK7 kinase and SCF FBXL18 E3 ligase
- (2019) Masanobu Ueda et al. GENES TO CELLS
- Fibroblasts from patients with idiopathic pulmonary fibrosis are resistant to cisplatin-induced cell death via enhanced CK2-dependent XRCC1 activity
- (2019) Jintaek Im et al. APOPTOSIS
- Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
- (2019) Mingjing Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical utility of custom-designed NGS panel testing in pediatric tumors
- (2019) Lea F. Surrey et al. Genome Medicine
- ATM in DNA repair in cancer
- (2019) Mei Hua Jin et al. PHARMACOLOGY & THERAPEUTICS
- Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study
- (2019) Marina Piljić Burazer et al. Diagnostic Pathology
- Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy
- (2019) Zheng Li et al. ONCOLOGY REPORTS
- Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
- (2019) David P. Hill et al. BMC CANCER
- PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
- (2019) Bin Shen et al. BRITISH JOURNAL OF CANCER
- Harnessing DNA Double-Strand Break Repair for Cancer Treatment
- (2019) Anika Trenner et al. Frontiers in Oncology
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
- (2018) Chaoyang Sun et al. CANCER CELL
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- 53BP1 inhibits the migration and regulates the chemotherapy resistance of ovarian cancer cells
- (2018) Shuhui Hong et al. Oncology Letters
- Integrative genomic and transcriptomic analysis of leiomyosarcoma
- (2018) Priya Chudasama et al. Nature Communications
- Spironolactone depletes the XPB protein and inhibits DNA damage responses in UVB-irradiated human skin
- (2018) Michael G. Kemp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway
- (2018) Yue Li et al. BMC CANCER
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
- (2018) Natalia Pajuelo-Lozano et al. Frontiers in Pharmacology
- CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
- (2018) Francesco Schettini et al. Frontiers in Oncology
- Mechanisms of DNA damage, repair, and mutagenesis
- (2017) Nimrat Chatterjee et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy
- (2017) Antonia A. Nemec et al. MOLECULAR CANCER RESEARCH
- AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells
- (2017) Ahrum Min et al. MOLECULAR CANCER THERAPEUTICS
- Livin enhances chemoresistance in head and neck squamous cell carcinoma
- (2017) Tae Mi Yoon et al. ONCOLOGY REPORTS
- Dual function of OCT2 and MATE1 in cisplatin induced nephrotoxicity
- (2017) Amr Ahmed EL-Arabey PHARMACOLOGICAL RESEARCH
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
- (2017) Chun-mei Kuang et al. Cell Death & Disease
- Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer
- (2017) Ethan Brill et al. Oncotarget
- High Expression of MRE11–RAD50–NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer
- (2016) BOLAG LTAN et al. ANTICANCER RESEARCH
- Targeting CDK4/6 in patients with cancer
- (2016) Erika Hamilton et al. CANCER TREATMENT REVIEWS
- Expression and clinical significance of Apollon in esophageal squamous cell carcinoma
- (2016) Rong Li et al. Molecular Medicine Reports
- Sensitizing thermochemotherapy with a PARP1-inhibitor
- (2016) Arlene L. Oei et al. Oncotarget
- Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells
- (2016) Sanjeevani Arora et al. Oncotarget
- Overexpression ofβ-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
- (2016) Long Li et al. Biomed Research International
- Nucleotide excision repair in humans
- (2015) Graciela Spivak DNA REPAIR
- Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs
- (2015) R. Planells-Cases et al. EMBO JOURNAL
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- VRAC: molecular identification as LRRC8 heteromers with differential functions
- (2015) Thomas J. Jentsch et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
- (2015) Rohit Prakash et al. Cold Spring Harbor Perspectives in Biology
- DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
- (2015) Euan A. Stronach et al. NEOPLASIA
- A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
- (2014) C. H. Chung et al. ANNALS OF ONCOLOGY
- CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis
- (2014) Lu Wang et al. CANCER CELL
- A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum
- (2014) Sergey Alekseev et al. CHEMISTRY & BIOLOGY
- New insights and challenges in mismatch repair: Getting over the chromatin hurdle
- (2014) Guo-Min Li DNA REPAIR
- The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
- (2014) Arindam Paul Frontiers in Bioscience-Landmark
- The CXCL12 G801A Polymorphism Is Associated with Cancer Risk: A Meta-Analysis
- (2014) Ke Zhu et al. PLoS One
- Association of Drug Transporter Expression with Mortality and Progression-Free Survival in Stage IV Head and Neck Squamous Cell Carcinoma
- (2014) Rolf Warta et al. PLoS One
- PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
- (2013) J.-m. Lee et al. ANNALS OF ONCOLOGY
- Ionizing Radiation-Induced DNA Damage, Response, and Repair
- (2013) Wil L. Santivasi et al. ANTIOXIDANTS & REDOX SIGNALING
- The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
- (2013) Feng Li et al. CELL
- DNA damage response in peripheral nervous system: Coping with cancer therapy-induced DNA lesions
- (2013) Ella W. Englander DNA REPAIR
- Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
- (2013) J. A. Sprowl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nucleotide Excision Repair in Eukaryotes
- (2013) O. D. Scharer Cold Spring Harbor Perspectives in Biology
- Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons
- (2012) Johnson J. Liu et al. BIOCHEMICAL PHARMACOLOGY
- BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest
- (2012) Ronit I. Yarden et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- XIAP Is a Predictor of Cisplatin-Based Chemotherapy Response and Prognosis for Patients with Advanced Head and Neck Cancer
- (2012) Xi-Hu Yang et al. PLoS One
- Histone H3R17me2a mark recruits human RNA Polymerase-Associated Factor 1 Complex to activate transcription
- (2012) J. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence
- (2011) David Balayssac et al. Expert Opinion On Drug Safety
- MSH3 Mediates Sensitization of Colorectal Cancer Cells to Cisplatin, Oxaliplatin, and a Poly(ADP-ribose) Polymerase Inhibitor
- (2011) Masanobu Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differences in Sensitivity to DNA-damaging Agents between XRCC4- and Artemis-deficient Human Cells
- (2011) Takanori KATSUBE et al. JOURNAL OF RADIATION RESEARCH
- High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
- (2011) Tai-Jan Chiu et al. Journal of Translational Medicine
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Identification of Novel Small Molecule Inhibitors of the XPA Protein Usingin SilicoBased Screening
- (2010) Tracy M. Neher et al. ACS Chemical Biology
- The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
- (2010) V. J. Weston et al. BLOOD
- Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer
- (2010) K Araki et al. BRITISH JOURNAL OF CANCER
- Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population
- (2010) Masakazu Toi et al. CANCER
- Secondary mutations of BRCA1/2 and drug resistance
- (2010) Kiranjit K. Dhillon et al. CANCER SCIENCE
- Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies
- (2010) Gerardo Gutiérrez-Gutiérrez et al. Clinical & Translational Oncology
- Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆
- (2010) Sanjeevani Arora et al. DNA REPAIR
- BRCA1 16 years later: DNA damage-induced BRCA1 shuttling
- (2010) Eddy S. Yang et al. FEBS Journal
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
- (2010) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Down-regulation of the Nucleotide Excision Repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells
- (2010) Maria Antonietta Sabatino et al. Molecular Cancer
- Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
- (2010) Jewel L. Podratz et al. NEUROBIOLOGY OF DISEASE
- Common mechanisms of PIKK regulation
- (2009) Courtney A. Lovejoy et al. DNA REPAIR
- Emerging common themes in regulation of PIKKs and PI3Ks
- (2009) Harri Lempiäinen et al. EMBO JOURNAL
- Impaired DNA damage response — An Achilles' heel sensitizing cancer to chemotherapy and radiotherapy
- (2009) Zbigniew Darzynkiewicz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas
- (2009) Hua-Yun Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy
- (2009) Waleed M. Abuzeid et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer
- (2008) Miguel Angel Pavón et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started